GSK Investigational Site — Kansas City, Kansas

GSK Investigational Site is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 30 clinical trials with 2 currently active.

Therapeutic areas: Myasthaenia Gravis, Neoplasms, Prostate, Haemophilus Influenzae Type b.

Sponsors: GlaxoSmithKline, Bellus Health Inc. - a GSK company, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 30 clinical trials on record, with 2 currently active. Their work covers Myasthaenia Gravis, Neoplasms, Prostate, Haemophilus Influenzae Type b.

Is GSK Investigational Site accredited by Crixeo Health?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.